Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 960 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 


 
REVIEW ARTICLE Table of Contents   
Year : 2018  |  Volume : 29  |  Issue : 2  |  Page : 276-283
Atypical hemolytic uremic syndrome: Laboratory characteristics, complement-amplifying conditions, renal biopsy, and genetic mutations


1 Department of Medicine, Jersey Shore University Medical Center, Seton Hall Hackensack-Meridian School of Medicine, Neptune, New Jersey, USA
2 Department of Medicine, Salisbury VA Health Care System, VCOM, North Carolina, USA

Correspondence Address:
Dr. Arif Asif
Department of Medicine, Jersey Shore University Medical Center, Seton Hall Hackensack-Meridian School of Medicine, Neptune, New Jersey
USA
Login to access the Email id


DOI: 10.4103/1319-2442.229287

PMID: 29657193

Rights and Permissions

Atypical hemolytic uremic syndrome (aHUS) is characterized by microangiopathic hemolytic anemia, consumptive thrombocytopenia, and widespread damage to multiple organs including the kidney. The syndrome has a high mortality necessitating the need for an early diagnosis to limit target organ damage. Because thrombotic microangiopathies present with similar clinical picture, accurate diagnosis of aHUS continues to pose a diagnostic challenge. This article focuses on the role of four distinct aspects of aHUS that assist clinicians in making an accurate diagnosis of aHUS. First, because of the lack of a single specific laboratory test for aHUS, other forms of thrombotic microangiopathies such as thrombotic thrombocytopenic purpura and Shiga toxin-associated HUS must be excluded to successfully establish the diagnosis of aHUS. Second, application of the knowledge of complement-amplifying conditions is critically important in making an accurate diagnosis. Third, when available, a renal biopsy can reveal changes consistent with thrombotic microangiopathy. Fourth, genetic mutations are increasingly clarifying the underlying complement dysfunction and gaining importance in the diagnosis and management of patients with aHUS. This review concentrates on the four aspects of aHUS and calls for heightened awareness in making an accurate diagnosis of aHUS.


[FULL TEXT] [PDF]*
Print this article  Email this article
    

  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Citation Manager
  Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed149    
    Printed0    
    Emailed0    
    PDF Downloaded59    
    Comments [Add]    

Recommend this journal